Medifast
MED
288 hedge funds and large institutions have $1.7B invested in Medifast in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 99 increasing their positions, 105 reducing their positions, and 40 closing their positions.
1.69% more ownership
Funds ownership: 84.34% → 86.03% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
6% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 105
3% less funds holding
Funds holding: 297 → 288 (-9)
10% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 40
17% less capital invested
Capital invested by funds: $2.05B → $1.7B (-$352M)
48% less call options, than puts
Call options by funds: $6.93M | Put options by funds: $13.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$26.1M |
| 2 |
CCM
Candlestick Capital Management
Greenwich,
Connecticut
|
+$14.5M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$11.4M |
| 4 |
CCPM
Cooper Creek Partners Management
New York
|
+$10.7M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$9.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$17.1M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$9.59M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$8.72M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.63M |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$6.98M |
MED Hedge Fund Activity: Q1 2022 in Review
288 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2022, worth a combined $1.7B — down 17% from $2.05B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of MED and 36 opened new positions — a net loss of 4 holders — while 105 trimmed existing stakes and 99 added.
The largest buyer was BlackRock, adding an estimated $26.1M. The largest seller was Acadian Asset Management, cutting an estimated $17.1M.
- 288 institutional investors held Medifast (MED) as of Q1 2022, down from 297 in Q4 2021.
- Funds reported $1.7B of Medifast stock for Q1 2022, down 17% quarter-over-quarter.
- 36 funds opened new Medifast positions in Q1 2022 and 40 closed out, a net change of -4 holders.
- The largest Medifast buyer in Q1 2022 was BlackRock, an estimated $26.1M added.
- The largest Medifast seller in Q1 2022 was Acadian Asset Management, an estimated $17.1M sold.
Based on aggregated 13F filings for Q1 2022.